论文部分内容阅读
目的:探讨血清氮端B型脑钠肽前体(NT-proBNP)水平对肺心病患者预后的评估价值,为临床诊疗工作提供参考价值。方法:选取82例肺心病患者资料,选取同时期体检健康者40例作为对照组,检测血清NT-proBNP水平,并通过统计学方法分析比较。结果:不同心功能分级患者与健康者NT-proBNP水平存在明显差异。肺心病患者心功能分级越低,其血清NT-proBNP水平则越高,且住院日越长、住院平均费用越高。结论:肺心病患者血清NT-proBNP水平可以预测其预后;检测肺心病患者血清NT-proBNP水平对诊断和治疗肺心病有重要意义。
Objective: To evaluate the value of serum N-terminal pro-brain natriuretic peptide (NT-proBNP) in predicting prognosis of patients with pulmonary heart disease and provide reference value for clinical diagnosis and treatment. Methods: The data of 82 patients with pulmonary heart disease were selected. Forty healthy subjects were selected as the control group at the same time. Serum NT-proBNP levels were measured and compared by statistical methods. Results: NT-proBNP levels were significantly different between patients with different cardiac function and healthy status. Coronary heart disease patients with lower heart function, the higher the level of serum NT-proBNP, and the longer hospital stay, the higher the average cost of hospitalization. Conclusion: The serum NT-proBNP level in patients with cor pulmonale can predict its prognosis. Detecting serum NT-proBNP levels in patients with cor pulmonale is of great significance for the diagnosis and treatment of pulmonary heart disease.